195 related articles for article (PubMed ID: 33576460)
1. Long non‑coding RNA KCNQ1OT1 promotes nasopharyngeal carcinoma cell cisplatin resistance via the miR‑454/USP47 axis.
Yuan F; Lou Z; Zhou Z; Yan X
Int J Mol Med; 2021 Apr; 47(4):. PubMed ID: 33576460
[TBL] [Abstract][Full Text] [Related]
2. LncRNA KCNQ1OT1 contributes to the cisplatin resistance of tongue cancer through the KCNQ1OT1/miR-124-3p/TRIM14 axis.
Qiao CY; Qiao TY; Jin H; Liu LL; Zheng MD; Wang ZL
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):200-212. PubMed ID: 31957833
[TBL] [Abstract][Full Text] [Related]
3. Long Noncoding RNA HOXA11-AS Modulates the Resistance of Nasopharyngeal Carcinoma Cells to Cisplatin via miR-454-3p/c-Met.
Lin FJ; Lin XD; Xu LY; Zhu SQ
Mol Cells; 2020 Oct; 43(10):856-869. PubMed ID: 33115978
[TBL] [Abstract][Full Text] [Related]
4. [Retracted] Long non‑coding RNA KCNQ1OT1 promotes nasopharyngeal carcinoma cell cisplatin resistance via the miR‑454/USP47 axis.
Yuan F; Lou Z; Zhou Z; Yan X
Int J Mol Med; 2024 Apr; 53(4):. PubMed ID: 38334226
[TBL] [Abstract][Full Text] [Related]
5. HOTAIR mediates cisplatin resistance in nasopharyngeal carcinoma by regulating miR-106a-5p/SOX4 axis.
Cao W; Sun Y; Liu L; Yu J; Ji J; Wang Y; Yang J
Bioengineered; 2022 Mar; 13(3):6567-6578. PubMed ID: 35227173
[TBL] [Abstract][Full Text] [Related]
6. HOXA11-AS induces cisplatin resistance by modulating the microRNA-98/PBX3 axis in nasopharyngeal carcinoma.
Li H; Huang J; Yu S; Li H; Zhou Y; Wu Q
Oncol Lett; 2021 Jun; 21(6):493. PubMed ID: 33968209
[TBL] [Abstract][Full Text] [Related]
7. FBXL19‑AS1 promotes the progression of nasopharyngeal carcinoma by acting as a competing endogenous RNA to sponge miR‑431 and upregulate PBOV1.
Dong H; Huang C; Huang J
Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34278444
[TBL] [Abstract][Full Text] [Related]
8. SATB1 Knockdown Inhibits Proliferation and Invasion and Decreases Chemoradiation Resistance in Nasopharyngeal Carcinoma Cells by Reversing EMT and Suppressing MMP-9.
Zhou D; Ye C; Pan Z; Deng Y
Int J Med Sci; 2021; 18(1):42-52. PubMed ID: 33390772
[No Abstract] [Full Text] [Related]
9. Knockdown of lncRNA ANRIL inhibits the development of cisplatin resistance by upregulating miR‑98 in lung cancer cells.
Wang X; Zhang G; Cheng Z; Dai L; Jia L; Jing X; Wang H; Zhang R; Liu M; Jiang T; Yang Y; Yang M
Oncol Rep; 2020 Sep; 44(3):1025-1036. PubMed ID: 32705261
[TBL] [Abstract][Full Text] [Related]
10. Circular RNA SET domain protein 3 promotes nasopharyngeal carcinoma proliferation, cisplatin resistance, and protein kinase B / mammalian target of rapamycin pathway activation by modulating microRNA-147a expression.
Deng G; Wang F; Song Y
Bioengineered; 2022 Mar; 13(3):5843-5854. PubMed ID: 35196205
[TBL] [Abstract][Full Text] [Related]
11. Effect of lncRNA KCNQ1OT1 on autophagy and drug resistance of hepatocellular carcinoma cells by targeting miR-338-3p.
Zhong W; Dai Q; Huang Q
Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(3):191-196. PubMed ID: 32538770
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA KCNQ1OT1 promotes the progression of gastric cancer via the miR-145-5p/ARF6 axis.
Zhong X; Wen X; Chen L; Gu N; Yu X; Sui K
J Gene Med; 2021 May; 23(5):e3330. PubMed ID: 33682985
[TBL] [Abstract][Full Text] [Related]
13. Long non‑coding RNA LUCAT1 contributes to cisplatin resistance by regulating the miR‑514a‑3p/ULK1 axis in human non‑small cell lung cancer.
Shen Q; Xu Z; Xu S
Int J Oncol; 2020 Oct; 57(4):967-979. PubMed ID: 32945379
[TBL] [Abstract][Full Text] [Related]
14. MiRNA-296-5p promotes the sensitivity of nasopharyngeal carcinoma cells to cisplatin via targeted inhibition of STAT3/KLF4 signaling axis.
Luo HQ; Wang Y; Ren J; Zhang QY; Chen Y; Chen MH; Huang NX; Wu MH; Tang XD; Li XY
Sci Rep; 2024 Mar; 14(1):6681. PubMed ID: 38509141
[TBL] [Abstract][Full Text] [Related]
15. Long non‑coding RNA TP73‑AS1 accelerates the progression and cisplatin resistance of non‑small cell lung cancer by upregulating the expression of TRIM29 via competitively targeting microRNA‑34a‑5p.
Luo S; Shen M; Chen H; Li W; Chen C
Mol Med Rep; 2020 Nov; 22(5):3822-3832. PubMed ID: 32901838
[TBL] [Abstract][Full Text] [Related]
16. Cinobufotalin powerfully reversed EBV-miR-BART22-induced cisplatin resistance via stimulating MAP2K4 to antagonize non-muscle myosin heavy chain IIA/glycogen synthase 3β/β-catenin signaling pathway.
Liu Y; Jiang Q; Liu X; Lin X; Tang Z; Liu C; Zhou J; Zhao M; Li X; Cheng Z; Li L; Xie Y; Liu Z; Fang W
EBioMedicine; 2019 Oct; 48():386-404. PubMed ID: 31594754
[TBL] [Abstract][Full Text] [Related]
17. miR‑182‑5p contributes to radioresistance in nasopharyngeal carcinoma by regulating BNIP3 expression.
He W; Jin H; Liu Q; Sun Q
Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33313953
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of lncRNA ANRIL represses tumorigenicity and enhances cisplatin-induced cytotoxicity via regulating microRNA let-7a in nasopharyngeal carcinoma.
Wang Y; Cheng N; Luo J
J Biochem Mol Toxicol; 2017 Jul; 31(7):. PubMed ID: 28117929
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA MAGI2-AS3/miR-218-5p/GDPD5/SEC61A1 axis drives cellular proliferation and migration and confers cisplatin resistance in nasopharyngeal carcinoma.
Cao C; Zhou S; Hu J
Int Forum Allergy Rhinol; 2020 Aug; 10(8):1012-1023. PubMed ID: 32450008
[TBL] [Abstract][Full Text] [Related]
20. Long non‑coding RNA DANCR promotes nasopharyngeal carcinoma cell proliferation and migration.
Hao Y; Zhao H; Jin X; He P; Zhang J; Dong Q; Shi W; Zhao M
Mol Med Rep; 2019 Apr; 19(4):2883-2889. PubMed ID: 30720067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
